Valneva SE 2015 IR
The report highlights Valneva's financial and operational progress in 2015, including the acquisition of Crucell Sweden AB and the DUKORAL® vaccine, which expanded its commercial travel vaccine portfolio. The company also co-founded BliNK Biomedical SAS to advance its antibody discovery platform. In terms of sustainability, Valneva joined the UN Global Compact in 2015, committing to its ten principles. The Group reported on its workforce of 414 employees, showing a strong gender balance with 61% women, and highlighted its environmental initiatives, such as reducing energy consumption at its Nantes site and utilizing 100% carbon-free electricity in Vienna.
Company: Valneva SE
Sector: Health Care
Country: France
Year: 2015
Type: IR
Pages: 433
Valneva SE
Registration Document
The report highlights Valneva's financial and operational progress in 2015, including the acquisition of Crucell Sweden AB and the DUKORAL® vaccine, which expanded its commercial travel vaccine portfolio. The company also co-founded BliNK Biomedical SAS to advance its antibody discovery platform. In terms of sustainability, Valneva joined the UN Global Compact in 2015, committing to its ten principles. The Group reported on its workforce of 414 employees, showing a strong gender balance with 61% women, and highlighted its environmental initiatives, such as reducing energy consumption at its Nantes site and utilizing 100% carbon-free electricity in Vienna.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Published
May 11, 2016
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees